Cephagenix in a €9M seed deal led by AdBio Partners and AbbVie Ventures
06 January 2025
06 January 2025
Total investments received (USD): 9.81M
Round value (USD): 9.81M
Round investors: AbbVie VenturesAdBio partners
Company: Cephagenix
Related deals
Octarine Bio in a €5 million series A extension with DSM Venturing, Óskare Capital, The Footprint Fund, EIFO, Unconventional Ventures, Edaphon
Investments
23 December 2025
Fida Biosystems raised €5 million series A extension from EIFO and Swedish venture fund FSG
Investments
02 December 2025
Belgium
Netherlands
Austria
Switzerland
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Ireland
Italy
Portugal
Spain
United Kingdom